SOURCE: GS MEDIA // Issues Investment Alert On (NASDAQ: BMTI), (NASDAQ: INVE), (NASDAQ: ALXA), (NASDAQ: SINA), (NASDAQ: JRCC) Is announcing Investment Highlights on BioMimetic Therapeutics (NASDAQ: BMTI), Identive (NASDAQ: INVE), Alexza (NASDAQ: ALXA), SINA (NASDAQ: SINA), James River (NASDAQ: JRCC)

Los Angeles, CA, November 19, 2012 - BioMimetic Therapeutics, Inc.(NASDAQ: BMTI) shares soared 70.36% to $7.07 in the morning hour after Wright Medical Group agreed to acquire BioMimetic Therapeutics for about $190 million in cash and stock as it looks to expand its extremities business. Wright agreed to pay $1.50 in cash and 0.2482 of a Wright share for each BioMimetic share.

Will BMTI Move Higher After Today’s Sudden Selling Activities? Don’t Miss The Free Trend Analysis here

Identive Group, Inc.(NASDAQ: INVE) stock gained 10.78% to $1.44 after the company announced that it has been selected by a U.S. federal agency within the Department of Homeland Security to implement its Hirsch-branded access control and security management systems at the agency's more than 200 locations nationwide. Identive's systems will secure entry and exit points at the agency's facilities and provide secure work environments for agency employees.

How Should Investors Trade INVE After The Recent Momentum, Find Out Here

Alexza Pharmaceuticals, Inc.(NASDAQ: ALXA) stock jumped 5.09% to $4.33 after the company announced that it has received a CHMP (Committee for Medicinal Products for Human Use) Day 180 Second List of Outstanding Issues (LoOI) from the European Medicines Agency (EMA) regarding its Marketing Authorization Application (MAA) for Adasuve™ (Staccato® loxapine).  The CHMP Day 180 Second LoOI for ADASUVE contains no major objections to the ADASUVE application, indicating that the two major objections outlined in the initial CHMP Day 180 LoOI have been resolved.

Get Free Special Trend Analysis On ALXA Here

SINA Corp(NASDAQ: SINA) shares increased 9.21% to $49.67. The company posted third-quarter net income of $9.9 million or $0.14 per share, compared to a net loss of $336.3 million or $5.10 per share in the comparable quarter last year. The company's adjusted income for the quarter declined to $11.7 million or $0.17 per share. Analysts expected loss of $0.11 per share for the quarter. Total revenues for the quarter rose to $152.38 million from $130.29 million in the prior-year quarter, while on a non-GAAP basis, revenues rose to $147.69 million from $125.60 million last year. Analysts had a consensus revenue estimate of $146.03 million for the quarter.

Get Free Special Trend Analysis On SINA Here

James River Coal Company(NASDAQ: JRCC) shares jumped 7.55% to $2.28. The company third-quarter adjusted loss was $1.23 per share, exceeding the $1.04 per-share loss analysts had estimated. Net loss widened to $20.6 million, or 59 cents per share, from $3.7 million, or 11 cents per share, a year earlier. Revenue fell 5% to $288.1 million, but was higher than the average estimate of $261.7 million.

Get Free Special Trend Analysis On JRCC Here

About Beststocksdaily

Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, Hot Stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at


The assembled information disseminated by is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. does expect that investors will buy and sell securities based on information assembled and presented in PLEASE always do your own due diligence, and consult your financial advisor.




Brain Burr


1419 Westwood Blvd Los Angeles, CA